Several lines of study have highlighted the role of LOXL1 in tumor progression, such as glioma [33], gastric cancer [34], colorectal cancer [35], pancreatic ductal adenocarcinoma (PDAC) [36], yet its effect on liver cancer remains unclear. Here, LOXL1 is linked to liver cancer.